Comparison of mammography and ultrasonography findings with pathology results in patients with breast cancer in Birjand, Iran
Keywords:
Biopsy; Breast cancer; Mammography; UltrasonographyAbstract
Background: Early diagnosis of breast cancer, the incidence of which among Iranian women is about a decade earlier than in developed countries, is important.
Objective: To compare mammography and ultrasonography findings with those of pathology in patients with breast cancer.
Methods: This descriptive cross-sectional study was performed using medical records of 79 patients with breast malignancies, who were referred to Imam Reza Hospital and private laboratories of Birjand, Iran, from December 2012 to December 2014. The patients’ information was recorded using a checklist, which included name, code, age, ultrasonography, and mammography results and pathology reports. The results of ultrasonography and mammography were compared with pathology findings as the gold standard. SPSS Version 21 was used for data analysis.
Results: The mean age of the patients was 46.94 ± 11.76 years. The results showed that 74.7%, 16.5%, and 7.6% of the patients had ductal carcinoma, lobular carcinoma, and mixed carcinoma, respectively. About 72.5%, 24.6%, and 2.9% of the patients had stage 2, 3, and 1 breast cancer, respectively. In addition, both breasts were involved in 1.3% of the patients. The ultrasound findings were positive and false negative in 97.5% and 2.5% of the cases. Moreover, the mammography results were positive and false negative in 98.7% and 1.3% of the patients.
Conclusion: This study showed that mammography is the preferred modality in screening breast cancer patients; the use of complementary tests such as ultrasonography is recommended, especially in high-risk women.
References
Chabner B, Longo D. Harrisons Manual of Oncology 2/E. McGraw-Hill Education; 2013.
Rockall AG, Hatrick A, Armstrong P, Wastie M. Diagnostic Imaging: Wiley E-Text. 7th Edition; 2013.
Brunicardi FC, Brunicardi F, Andersen D, Billiar T, Dunn D, Pollock RE, et al. Schwartz's Principles of
Surgery. 9th Edition. McGraw-Hill Education; 2009.
Harirchi I, Karbakhsh M, Kashefi A, Momtahen AJ. Breast cancer in Iran: results of a multi-center study.
Asian Pac J Cancer Prev. 2004; 5(1): 24-7. PMID: 15075000.
Haghighatkhah H, Shafii M, Khayamzade M, Molaii H, Akbari M. Determination of compliance with
mammography or ultrasound reports of pathology reports malignant and benign disease breast. Quart Iran
Breast Dis. 2009; 2: 27-32.
Berg WA, Blume JD, Cormack JB, Mendelson EB, Lehrer D, Böhm-Vélez M, et al. Combined screening
with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer.
JAMA. 2008; 299(18): 2151-63. doi: 10.1001/jama.299.18.2151. PMID: 18477782, PMCID:
PMC2718688.
Harirchi I, Ebrahimi M, Zamani N, Jarvandi S, Montazeri A. Breast cancer in Iran: a review of 903 case
records. Public Health. 2000; 114(2): 143-5. doi: 10.1038/sj.ph.1900623. PMID: 10800155.
Sadjadi A, Nouraie M, Mohagheghi MA, Mousavi-Jarrahi A, Malekezadeh R, Parkin DM. Cancer
occurrence in Iran in 2002, an international perspective. Asian Pac J Cancer Prev. 2005; 6(3): 359-63.
PMID: 16236000.
Mousavi SM, Montazeri A, Mohagheghi MA, Jarrahi AM, Harirchi I, Najafi M, et al. Breast cancer in Iran:
an epidemiological review. Breast J. 2007; 13(4): 383-91. doi: 10.1111/j.1524-4741.2007.00446.x. PMID:
Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005; 55(2): 74- 108. doi: 10.3322/canjclin.55.2.74. PMID: 15761078.
DeSantis C, Ma J, Bryan L, Jemal A. Breast cancer statistics, 2013. CA Cancer J Clin. 2014; 64(1): 52-62.
doi: 10.3322/caac.21203.
Assi HA, Khoury KE, Dbouk H, Khalil LE, Mouhieddine TH, El Saghir NS. Epidemiology and prognosis
of breast cancer in young women. J Thorac Dis. 2013; 5(Suppl 1): S2-8. doi: 10.3978/j.issn.2072- 1439.2013.05.24. PMID: 23819024, PMCID: PMC3695538.
Farokh D, Azarian A, Homaii F, Yaghubi N, Khaje deloii M. Compliance review findings of
mammography, ultrasound and Histopathology in women with breast cancer less than 50 years. Med J
Mashhad Univ Med Sci. 2012; 2(4): 195-200.
Shafiee SAB, Rafii M, Kalantari M. Evaluation of the results matched the findings of clinical examination
and mammography in detecting breast cancer. Iran J Surg. 2007; 15: 3.
Ghare khanloo F, Tarabian S, Kamrani S. The study of the role of Additional ultrasound in diagnosis of
breast cancer. J Hamadan Univ Med Sci Health Serv. 2010; 4(5): 60-7.
Ahmadinezhad N, Shahriarian S, Ghasemi A, Giti M. Sensitivity and specificity of color Doppler
sonography and power Doppler sonography in differentiating benign and malignant breast. J Tehran Univ
Med Sci. 1980; 4: 277-82.
Leconte I, Feger C, Galant C, Berlière M, Berg BV, D'Hoore W, et al. Mammography and subsequent
whole-breast sonography of nonpalpable breast cancers: the importance of radiologic breast density. AJR
Am J Roentgenol. 2003; 180(6): 1675-9. doi: 10.2214/ajr.180.6.1801675.
Sickles EA, Filly RA, Callen PW. Breast cancer detection with sonography and mammography:
comparison using state-of-the-art equipment. AJR Am J Roentgenol. 1983; 140(5): 843-5. doi:
2214/ajr.140.5.843. PMID: 6601422.
Peyman A, Abbasi Z, Shishegar F. the Comparison between MRI and mammography to diagnosis of breast
masses. The First International Congress on Midwifery and Reproductive Health; Iran, Mashhad; 2011.
Berg WA, Blume JD, Adams AM, Jong RA, Barr RG, Lehrer DE, et al. Reasons women at elevated risk of
breast cancer refuse breast MR imaging screening: ACRIN 6666. Radiology. 2010; 254(1): 79-87. doi:
1148/radiol.2541090953. PMID: 20032143, PMCID: PMC2811274.
Berg WA, Zhang Z, Lehrer D, Jong RA, Pisano ED, Barr RG, et al. Detection of breast cancer with
addition of annual screening ultrasound or a single screening MRI to mammography in women with
elevated breast cancer risk. JAMA. 2012; 307(13): 1394-404. doi: 10.1001/jama.2012.388. PMID:
, PMCID: PMC3891886.
Published
Issue
Section
License
Copyright (c) 2020 KNOWLEDGE KINGDOM PUBLISHING
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
